Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
4nQmDhmCQnEs8P6M
